baber/WOPTO huggingface dataset:
Patent NZ-519773-A (NZ)
Title: Gamma-IFN liquid-droplet aerosol and method
Inventor: EMLEN J WOODRUFF
IPC: A61K9/08
Filed: 2000-12-22
Abstract: .A liquid-droplet aerosol composition for delivery to a patient's respiratory tract: (a) formed by placing an aqueous gamma-IFN solution having a known, selected gamma-IFN biological activity, and comprising a stabilizing agent and a dispersing agent, against a plate having defined-size openings, and forcing the solution through said openings under conditions effective to form aqueous droplets having: (i) a distribution of size that is less than 2 standard deviations from the volume mean diameter of the droplets, wherein the volume mean diameter is in a selected size range selected from the group consisting of: less than 1 micron; 1-3 microns; 3-5 microns; 5-10 microns; and greater than 10 microns; (ii)' a gamma-IFN biological activity substantially the same as that of the solution; and (iii) a gamma-IFN molecular size distribution substantially the same as that of the solution; and (b) characterized by an aerosol of aqueous droplets having: (i) a distribution of sizes that is less than 2 standard deviations from the volume mean diameter of the droplets, wherein the volume mean diameter is in a selected size range selected from the group consisting of: less than 1 micron; 1-3 microns; 3-5 microns; 5-10 microns; and greater than 10 microns; (ii) a gamma-IFN biological activity substantially the same as that of the solution; and (iii) a gamma-IFN molecular size distribution substantially the same as that of the solution.
Patent NZ-523673-A (NZ)
Title: Telescopically connected multiple component container with a base receptacle and at least one ring element and method of molding same
Inventor: JALET VINCENT
IPC: B65D8/04
Filed: 2003-01-16
Abstract: A container formed of multiple components wherein one of the components is a receptacle having a closed bottom and the other component or components define a complete container. The receptacle component has a bottom and peripheral walls, terminating in an open upwardly directed mouth. The second component consists of a ring with a wide side walls conforming to the peripheral walls of the base component and is partially telescopically engaged therewith. Three zones are provided, a lower zone comprising the exposed portion of the base, a central zone defined by the overlapping ring and upper portion of the base, and an upper zone consisting solely of the ring. With the two components as different colours or shades of colours, and at least the upper component being translucent, the resultant three zones will be different colours.
Patent NZ-524024-A (NZ)
Title: A method for the production of tannin from the outer bark of pinus radiata
Inventor: NAKAMOTO YUSHO
IPC: C09J161/00
Filed: 2003-02-05
Abstract: A method of producing tannin is disclosed, wherein the method comprises the steps of: separating radiata pine (Pinus radiata) bark into an outer bark and an inner bark; extracting only the outer bark with a lower alcohol or a lower alcohol/aqueous solvent; concentrating a tannin solution; and removing the solvent to yield a solid product of tannin.
Patent NZ-524519-A (NZ)
Title: Liquid formulation of metformin
Inventor: CHANDRAN RAVI
IPC: A61K31/155
Filed: 2001-08-07
Abstract: A liquid pharmaceutical composition for oral administration to a subject in need thereof which comprises a therapeutically effective amount of metformin or its pharmaceutically acceptable salt thereof in association with a pharmaceutically acceptable liquid carrier; and the use of the composition for the preparation of a medicament for treating diabetes or hyperglycemia.
Patent NZ-526379-A (NZ)
Title: Radiation triggerable oxygen scavenging article with a radiation curable coating
Inventor: SPEER DREW V
IPC: C08J7/043
Filed: 2001-12-11
Abstract: An article is disclosed which includes a first and second outer surface, and a first layer including an oxygen scavenger, the first outer surface including a printed image, and a radiation-curable varnish covering at least a portion of the image. Also disclosed is a method which includes providing an article including a first and second outer surface, and a first layer including an oxygen scavenger; printing an image on the first outer surface; and applying a radiation-curable varnish on the first outer surface so as to cover at least a portion of the image; A multilayer article that includes a first and second outer surface, and a first layer including an oxygen scavenger; wherein the first outer surface includes a radiation-curable printed image; and a method that includes providing an article including a first and second outer surface, and a first layer including an oxygen scavenger; and printing a radiation-curable image on the first outer surface.
Patent NZ-527056-A (NZ)
Title: Modulating developmental transitions in plants
Inventor: DE BOER ANNE DOUWE
IPC: C07K14/415
Filed: 2002-01-15
Abstract: A method for modulating a developmental transition of a plant comprises modulating expression of RING finger or RING-H2 protein the plant and further providing ubiquitation and/or proteolysis of a target protein wherein the target protein modulates developmental transition of a plant. Also described is a nucleic acid that encodes a plant RING finger or RING-H2 protein.
Patent NZ-536845-A (NZ)
Title: Disinfecting handrail of movable walkway with ultraviolet light
Inventor: LOMBARD MORNE ROBERT
IPC: B66B/
Filed: 2003-04-25
Abstract: An escalator/movable walkway with a movable handrail is provided with a disinfecting device 50 to disinfect the endless band 26 of the handrail as the band moves past the disinfecting device. The disinfecting device includes ultraviolet light tubes 60 and reflecting surfaces 52, 54, 62 to irradiate the entire exposed cross-sectional periphery of the band to disinfecting and germicidal radiation. The device is best installed to disinfect the band on the return leg of the band movement.
Patent NZ-541587-A (NZ)
Title: Use of adenosine receptor agonists in therapy
Inventor: RICHARDSON PETER
IPC: A61P25/08
Filed: 2004-03-05
Abstract: Disclosed is the use of adenosine receptor agonists of formula (I), where R is C1-4 alkoxy and X is OH, for use in a medicament for the prevention, treatment or amelioration of cancer, inflammation, auto-immune disease, ischemia-reperfusion injury, epilepsy, sepsis, septic shock, neurodegeneration (including Alzheimer's Disease), muscle fatigue or muscle cramp. The compounds are effective at very low doses, and so can be administered at doses at which serious side effects are not observed.
Patent NZ-542945-A (NZ)
Title: Water storage system
Inventor: GREEN RONALD WILLIAM
Filed: 2005-10-10
Abstract: A water storage system comprises a number of pre-formed modular water tanks which are inter-connected to allow water to flow between them. The system also includes a pump and controls. The tanks of the system are shallow relative to their width
Patent NZ-544789-A (NZ)
Title: Dithia-azaspiro-nonane and decane derivatives as inhibitors of serine proteases
Inventor: BRITT SHAWN D
IPC: C07D207/12
Filed: 2004-07-16
Abstract: Disclosed is a compound of formula I, or a pharmaceutically acceptable salt thereof, wherein X and XÆ may form a ring as shown, and wherein the other substituents are as described in the specification. Also disclosed is the use of the compound as an inhibitor of a serine protease, such as HCV NS3 protease. Also disclosed is a method of eliminating or reducing HCV contamination of a biological sample or medical or laboratory equipment comprising contacting the object with a composition containing the compound.
Patent NZ-551942-A (NZ)
Title: Cold roll forming apparatus for creating structual elements from a strip of metal with hollow flanges joined by a web
Inventor: BARTLETT ROSS JOHN
IPC: B21D19/02
Filed: 2005-06-22
Abstract: A cold roll forming mill for the manufacture of hollow flange seam welded beams from a single strip of metal is disclosed. The mill comprises a forming station; a seam guide and welding station as well as a shaping station. The mill is characterized in that either or both of the forming station and the shaping station (12) comprises independently supported side engaging roll combinations (131) adapted to roll either or both of opposite sides of the metal strip (133). Adjacent transverse pairs of the side engaging roll combinations (131) are selectively movable relative to each other in a transverse direction perpendicular to a direction of travel of the strip through the mill. All forming and shaping rolls of either or both of the forming station and the shaping station (12) consist of the side engaging roll combinations.
Patent NZ-553635-A (NZ)
Title: Capsule with sealing means
Inventor: YOAKIM ALFRED
IPC: A23L23/00
Filed: 2005-10-20
Abstract: A capsule 1 containing beverage ingredients 3 and designed for insertion in a beverage production machine in which a pressurised liquid enters the capsule 1, interacts with the ingredients 3 in the capsule 1 and drains from the capsule 1 as a beverage. The capsule 1 has a resilient sealing member 8 made of a different material from the material of the rest of the capsule 1, on the outer wall of the capsule 1. The material of the sealing member has a lower hardness than the material of the rest of the capsule 1. The sealing member is configured to be compressible and form a sealing engagement with a matching pressing surface of the beverage production device.
Patent NZ-554055-A (NZ)
Title: Method and apparatus for the manufacture of conduit with assembled components and conduit assembly made therefrom
Inventor: CAMPAU DANIEL
Filed: 2007-03-22
Abstract: A method for performing a manufacturing operation at a plurality of locations along a length of flexible conduit to thereby fabricate a conduit assembly is disclosed. The method comprises providing a length or previously fabricated flexible conduit ('conduit') 12 which has a longitudinally extending sidewall which defines an enclosed inner cavity. The conduit is fed through a manufacturing station 25 adapted to perform the manufacturing operation. The manufacturing station is periodically operated to perform the manufacturing operation at a plurality of locations along the length of the conduit. A support device 17 is positioned within the inner cavity of the conduit and at the manufacturing station to support the sidewall. The support device also maintains the integrity of the conduit while the manufacturing operation is being performed, whilst not being attached to any other structure via the inner cavity.
Patent NZ-555559-A (NZ)
Title: Method and apparatus for maintaining and monitoring sleep quality during therapeutic treatments
Inventor: BURTON DAVID
IPC: A62B7/00
Filed: 2003-10-09
Abstract: A method of controlling the delivery of a gas from a gas delivery device is provided. The method includes the steps of: - monitoring a physiological parameter in a subject; - delivering gas from the gas delivery device at a set level; - determining onset of arousal from the physiological parameter; - determining if onset of arousal is caused by upper airway resistance or gas delivery; and - adjusting the level of delivered gas based on whether the arousal is attributed to upper airway resistance or gas delivery. A gas delivery device for enacting the method is also disclosed.
Patent NZ-564717-A (NZ)
Title: Marker assisted selection of bovine for desired milk fat colour
Inventor: THOMAS NATALIE LOUISE
IPC: C12Q1/68
Filed: 2007-12-21
Abstract: Provided is a method of determining genetic merit of a bovine, wherein the genetic merit is with respect to a milk content phenotype or a milk colour phenotype, the method comprising determining the BCMO1 allelic profile of the bovine and determining the genetic merit of the bovine on the basis of the BCMO1 allelic profile. Further provided are specific DNA probes and primers for the alleles, polypeptides corresponding to the alleles, bovines selected by the method and milk and milk products obtained from the selected bovines.
Patent NZ-566099-A (NZ)
Title: Banner support system with secure housing for containing halyard fastener and lenght of halyard lowered in raising banner
Inventor: MCCUDDEN LACHLAN ARTHUR DEAN
IPC: E04H12/32
Filed: 2006-08-25
Abstract: A banner raising apparatus is described for use with a halyard (228) for raising and lowering a banner. The apparatus is mounted to a generally vertical support surface (222) and comprises an upper halyard guide (220) mounted at an upper portion of the support surface and guiding the halyard travelling in a secure halyard passageway. A halyard fastener (218) is operable to releasably fasten the halyard exiting the secure halyard passageway adjacent a lower portion of the support surface, and a secure housing (212) is mounted externally of the support surface adjacent the lower portion, the secure housing configured to contain the halyard fastener and having sufficient internal volume to securely house the halyard of a raised banner. The secure housing is configured to enable access to the halyard. An elongate conduit defining the secure halyard passageway may be mounted externally to the support surface. The secure halyard passageway may be a secure internal cavity defined in the support surface.
Patent NZ-570014-A (NZ)
Title: Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
Inventor: CHAPLIN JASON HUGH
IPC: A61K31/33
Filed: 2007-02-02
Abstract: Disclosed is a compound of formula (I) or a salt thereof wherein; X, R1A, R1B, R1C R1D, L and R2A-R2E and Q are defined in the specification. Also disclosed is the use of said compound in the treatment of cancer.
Patent NZ-573210-A (NZ)
Title: Foot operable latch
Inventor: GRIFFITHS MERVYN RUSSELL
IPC: E05C17/16
Filed: 2010-03-01
Abstract: A latch 1 for releasably retaining a hinged panel 2 in an open or closed position, comprises a base plate 3, an arm 11 extending from the base plate 3, and release means 12. The base plate 3 is attachable to a fixed support structure in the form of a post 4. The arm 11 is spring loaded with respect to the base plate 3, and includes retention means 12 for receiving and retaining a bottom edge of the hinged panel 2. The release means 12 releases the hinged panel 2 from the retention means 12 and/or the arm 11, and is in the form of a foot operable portion 15 located at or towards the distal end of the arm 11.
Patent NZ-573843-A (NZ)
Title: C-phenyl 1-thioglucitol compound
Inventor: KAKINUMA HIROYUKI
IPC: A61K31/382
Filed: 2007-06-28
Abstract: Disclosed is a C-phenyl 1-thioglucitol compound represented by the formula (I), a pharmaceutically acceptable salt thereof, or a hydrate of the compound or the pharmaceutically acceptable salt. Also disclosed is the compound or the salt or the solvate of formula (I), can inhibit the SGLT1 and SGLT2 activity. Also disclosed is the use of the said compound or the salt or the solvate in the manufacture of a medicament for treating or preventing diabetes.
Patent NZ-574598-A (NZ)
Title: Sheeting wherein each of the surface microlenses is associated with one of a plurality of images within the sheeting
Inventor: DUNN DOUGLAS S
IPC: G02B27/00
Filed: 2007-07-17
Abstract: Sheeting that includes a layer of a shape-memory polymer material having a surface of micro lenses is disclosed. In the sheeting, each of the microlenses is associated with one of a plurality of images within the sheeting. The layer of the shape-memory polymer material is responsive to an external stimulus; e.g., temperature, solvent, or moisture; by transitioning from a first state in which an optical property of the microlenses has a first value to a second state in which the optical property of the microlenses has a second value. The microlenses have refractive surfaces that transmit light to positions within the sheeting to produce a composite image from the images formed within the sheeting. At least one of the images is a partially complete image, and each microlens is associated with a different one of the images.
Patent NZ-576467-A (NZ)
Title: Smoothened polypeptides and methods of use
Inventor: TARASOVA NADYA
IPC: C07K14/705
Filed: 2007-10-30
Abstract: Disclosed is an isolated or purified polypeptide or peptidomimetic comprising an amino acid sequence of a portion of a Smoothened (SMO) protein that inhibits proliferation of a diseased cell. Also disclosed are functional variants, fragments, fatty acid derivatives, conjugates and pharmaceutical compositions.
Patent NZ-577426-A (NZ)
Title: Synthetic two piece induction seal products
Inventor: THORSTENSEN-WOLL ROBERT WILLIAM
IPC: B65D53/02
Filed: 2007-11-21
Abstract: Disclosed is a two-piece induction seal (100) product comprising: a synthetic compressing agent absorbing material (124), said synthetic material comprising a monolayer plastic formed from intertwined synthetic fibers; a wax layer (126); an adhesive layer (130); an inductive innerseal membrane (128) having a first side and a second side thereof, with the adhesive layer at the first side of said membrane and the second side of said membrane being detachably bound to said synthetic material with said wax layer; and said intertwined synthetic fibers being further suitable for absorbing substantially all of said wax layer when said wax layer is in liquid form.
Patent NZ-583941-A (NZ)
Title: Perfluoroalkyl sulphonamide polymers prepared by free-radical polymerisation of vinylic monomers
Inventor: SEVERAC ROMAIN
IPC: C08F14/18
Filed: 2008-09-30
Abstract: Disclosed is a perfluoroalkyl sulphonamide copolymer prepared by free-radical polymerisation of at least two different vinylic monomers, wherein the fluoropolymer comprises hydrophobic fluorinated acrylic units, hydrophobic vinylic units, optionally other monomeric units, and no more than five weight percent of any monomeric units which are hydrophilic, wherein x is a non-zero positive integer denoting the number of hydrophobic fluorinated acrylic units; y is a non-zero positive integer denoting the number of hydrophobic vinylic units; the sum of x and y is at least 21; each Rf independently represents a perfluorinated alkyl group, optionally interrupted by oxygen, having at least 2 carbon atoms; each R1 is independently chosen from a C1-C20 hydrocarbylene; each R8 is independently chosen from hydrocarbyl or hydrogen; each R2 is independently chosen from hydrogen, fluorine, or a C1-C4 alkyl; each m is independently 0 or 1; each Rh independently represents a linear or branched hydrocarbon group having at least 4 carbon atoms; each Z is divalent and independently selected from the group consisting of -OC(O)-, -HNC(O)-, and phenylene; and each R3 is independently chosen from hydrogen or a C1-C4 alkyl group. Further disclosed is a method for imparting water and/or oil repellency to a substrate such as leather, the method comprising contacting the substrate with the fluoropolymer as defined above.
Patent NZ-589929-A (NZ)
Title: Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
Inventor: PATEL JYOTI R
IPC: C07D213/64
Filed: 2006-01-05
Abstract: Disclosed herein is an adamantlyl derivative of formula (I), wherein A1 is formyl or alkyl substituted with cyano, sulfanylidene, or sulfo; and the other substituents are as defined within the specification; processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 enzyme and are therefore useful in the treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, onset of cognitive decline, dementia, steroid-induced actue psychosis, depression, anxiety or a condition that involves excessive glucocorticoid action. Examples of preferred compounds include: · E-4-[2-(4-chlorophenoxy)-2-methyl-propionylamino]-adamantane-1-carbaldehyde; · E-{ 4-[2-(4-chlorophenoxy)-2-methyl-propionylamino]-adamantan-1-yl} -acetonitrile; · N-{ (E)-5-[(thioacetyl)methyl]-2-adamantyl} -2-(4-chlorophenoxy)-2-methylpropanamide; · N-{ (E)-5 -[(sulfonic acid)methyl] -2-adamantyl} -2-(4-chlorophenoxy)-2-methylpropanamide; · ((E)-4-{ [2-(4-chlorophenoxy)-2-methylpropanoyl] amino} -1-adamantyl)acetic acid; · 2-(4-chlorophenoxy)-N-[(E)-5-(hydroxymethyl)-2-adamantyl]-2-methylpropanamide; and · E-4-[2-(2-chloro-4-fluorophenoxy)-2-methyl-propionylamino]-adamantane-carbonitrile.
Patent NZ-590080-A (NZ)
Title: 7,8,9,10-Tetrahydro-6H-pyrimido[1,2-a]azepin-4-one, 6,7,8,9-tetrahydro-5H-1,4a,7-triazabenzocyclohepten-4-one and 6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one derivatives
Inventor: FAYOL AUDE
IPC: A61K31/4375
Filed: 2009-06-25
Abstract: Disclosed are 7,8,9,10-tetrahydro-6H-pyrimido[1,2-a]azepin-4-one, 6,7,8,9-tetrahydro-5H-1,4a,7-triazabenzocyclohepten-4-one and 6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one derivatives as represented by the general formula (I), wherein X represents a methylene, NH, a nitrogen atom substituted by a CO2-alkyl group; R1 represents a 2, 3 or 4-pyridine ring or a 2, 4 or 5-pyrimidine ring, the ring being optionally substituted by an alkyl group, an alkoxy group or a halogen atom; R2 represents a hydrogen atom, an alkyl group or a halogen atom; R3 represents an alkyl group which is optionally substituted; R4 represents a hydrogen atom, or an alkyl group; m represents 1 to 2 when X is a methylene or m represents 2 when X is nitrogen; in the form of a free base, or of an addition salt with an acid, or a solvate thereof, or a hydrate thereof. Further disclosed is a GSK3b inhibitor medicament which comprises a compound as defined above, for the treatment of neurodegenerative diseases (such as Alzheimer's disease, Parkinson's disease, tauopathies, vascular dementia; acute stroke, traumatic injuries etc.); non-insulin dependent diabetes; obesity; manic depressive illness; schizophrenia; alopecia; cancer; parenchymal renal diseases or muscle atrophy; malaria; bone diseases etc.
Patent NZ-595370-A (NZ)
Title: Assembly for the temporary attachment of a vertical masonry guide to the inner leaf of a cavity wall
Inventor: FRANSEN JANWILLEM
IPC: E04G21/18
Filed: 2010-03-16
Abstract: Assembly for temporarily attaching a vertical masonry guide to an inner leaf of a cavity wall during laying of the bricks of an outer leaf of a cavity wall, comprising an inner leaf attaching part for attaching the assembly to the inner leaf, a masonry guide attaching part for attaching the assembly to the masonry guide, and a connecting part for mutually connecting the inner leaf attaching part and the masonry guide attaching part.
Patent NZ-598030-A (NZ)
Title: Cannabinoid active pharmaceutical ingredient for improved dosage forms
Inventor: KUPPER ROBERT J
IPC: A61K31/352
Filed: 2006-07-14
Abstract: ABSTRACT - 598030 The disclosure relates to a composition comprising crystalline trans-(+-)-(9-tetrahydrocannabinol and a pharmaceutically-acceptable carrier, wherein said pharmaceutically-acceptable carriers can be solid or dry components; or they can be liquids, such as water or oils, including those of petroleum, animal, vegetable or synthetic origin, such as peanut oil, soybean oil, mineral oil, sesame oil, and the like in which said tetrahydrocannabinol can be suspended; said carriers can also be selected from saline, gum acacia, gelatin, starch paste, talc, keratin, colloidal silica, urea, and the like; and wherein said composition can take the form of a suspension, tablet, pill, pellet, suppository, or capsule, (e.g., a capsule containing a powder, microparticles, multiparticulates, or nanoparticles) form or any other form suitable for use. These compositions are suitable for treating or preventing a condition such as, inter alia, pain, emesis, loss of appetite or weight loss.